A quality evaluation of guidelines on five different viruses causing public health emergencies of international concern

Zhao, Song; Cao, Jiangwei; Shi, Qianling; Wang, Zijun; Estill, Janne; Lu, Shuya; Luo, Xufei; Zhao, Junxian; Zhang, Hairong; Wang, Jianjian; Wang, Qi; Xun, Yangqin; Zhang, Jingyi; Lv, Meng; Liu, Yunlan; Nie, Xiaomin; Wang, Ling; Zhang, Xianzhuo; Wei-guo, LI; Liu, Enmei; Wang, Xiaohui; Chen, Yaolong; Evidence, Covid

doi:10.21037/atm.2020.03.130

Cited by 24 publications

(27 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our results suggested that the quality of diagnosis and treatment guidelines for COVID‐19 was low, especially regarding stakeholder involvement, rigor of development, and applicability. This was generally consistent with the findings of two earlier studies 6,7 . There are three potential reasons for this.…”

Section: Discussionsupporting

confidence: 92%

“…4,5 However, due to the urgency of the situation, the quality of those guidelines and the consistency of recommendations are unclear. Previous studies 6,7 have shown that the clinical guidelines of COVID‐19 lacked detail and covered a narrow range of topics. Another study 8 suggested inconsistency between some recommendations of some clinical practice guidelines compared with those of the WHO.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Consistency of recommendations and methodological quality of guidelines for the diagnosis and treatment of COVID‐19

Luo

Liu

Ren

et al. 2021

J Evidence Based Medicine

Self Cite

View full text Add to dashboard Cite

Objective Since the beginning of the COVID‐19 epidemic, a large number of guidelines on diagnosis and treatment of COVID‐19 have been developed, but the quality of those guidelines and the consistency of recommendations are unclear. The objective of this study is to evaluate the quality of the diagnosis and treatment guidelines on COVID‐19 and analyze the consistency of the recommendations of these guidelines. Methods We searched for guidelines on diagnosis and/or treatment of COVID‐19 through PubMed, CBM, CNKI, and WanFang Data, from January 1, 2020 to August 31, 2020. In addition, we also searched official websites of the US CDC, European CDC and WHO, and some guideline collection databases. We included diagnosis and/or treatment guidelines for COVID‐19, including rapid advice guidelines and interim guidelines. Two trained researchers independently extracted data and four trained researchers evaluated the quality of the guidelines using the AGREE II instruments. We extracted information on the basic characteristics of the guidelines, guideline development process, and the recommendations. We described the consistency of the direction of recommendations for treatment and diagnosis of COVID‐19 across the included guidelines. Results A total of 37 guidelines were included. Most included guidelines were assessed as low quality, with only one of the six domains of AGREE II (clarity of presentation) having a mean score above 50%. The mean scores of three domains (stakeholder involvement, the rigor of development and applicability) were all below 30%. The recommendations on diagnosis and treatment were to some extent consistent between the included guidelines. Computed tomography (CT), X‐rays, lung ultrasound, RT‐PCR, and routine blood tests were the most commonly recommended methods for COVID‐19 diagnosis. Thirty guidelines were on the treatment of COVID‐19. The recommended forms of treatment included supportive care, antiviral therapy, glucocorticoid therapy, antibiotics, immunoglobulin, extracorporeal membrane oxygenation (ECMO), convalescent plasma, and psychotherapy. Conclusions The methodological quality of currently available diagnosis and treatment guidelines for COVID‐19 is low. The diagnosis and treatment recommendations between the included guidelines are highly consistent. The main diagnostic methods for COVID‐19 are RT‐PCR and CT, with ultrasound as a potential diagnostic tool. As there is no effective treatment against COVID‐19 yet, supportive therapy is at the moment the most important treatment option.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Introductionmentioning

confidence: 99%

Consistency of recommendations and methodological quality of guidelines for the diagnosis and treatment of COVID‐19

Luo

Liu

Ren

et al. 2021

J Evidence Based Medicine

Self Cite

View full text Add to dashboard Cite

show abstract

“…Based on the World Health Organization guidelines and the items of the COGS and AGREE II, this international reporting tool was developed in strict accordance with existing framework and the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) network approach. Consisting of 22 items across 7 domains, the RIGHT Statement has been widely applied to clinical practice, public health and health policy guidelines [ [9] , [10] , [11] ].…”

Section: Background and Development Of The Right-tcmmentioning

confidence: 99%

The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and Explanation

Xie

Xia

Chen

et al. 2020

Pharmacological Research

Self Cite

View full text Add to dashboard Cite

show abstract

“…Published research on COVID-19 is increasing rapidly [1] , [2] , [3] , [4] , [5] . Clinicians, patients, citizens and others decision-makers are pressured to make urgent decisions and adapt to the rapid and changing demands in clinical and public health [6] .…”

mentioning

confidence: 99%

Getting trustworthy guidelines into the hands of decision-makers and supporting their consideration of contextual factors for implementation globally: recommendation mapping of COVID-19 guidelines

Lotfi

Stevens

Akl

et al. 2021

Journal of Clinical Epidemiology

View full text Add to dashboard Cite

Published research on COVID-19 is increasing rapidly and integrated in guidelines. The trustworthiness of guidelines can vary depending on the methods used to assemble and evaluate the evidence, the completeness and transparency of reporting on the process undertaken and how conflicts of interest are addressed. With a global consortium of partners and collaborators, we have created a catalogue of COVID-19 recommendations as our direct response to the increased need for structured access to high quality guidance in the field. The COVID19 map of recommendations and gateway to contextualization ( https://covid19.recmap.org ) is a living project: emerging guideline literature is added on an ongoing basis, allowing granular access to individual recommendations. Building on prior work on mapping recommendations for the World Health Organization tuberculosis guidelines, a novel feature of this map is the self-directed contextualization of the recommendations using the GRADE-Adolopment approach to adopt, adapt or synthesize de novo recommendations for context specific questions. Through our map, stakeholders access the evidence underpinning a recommendation, select what needs to be contextualized and go through the steps of development of adapted recommendations. This one-stop shop portal of evidence-informed recommendations, built with intuitive functionalities, easy to navigate and with a support team ready to guide users across the maps, represents a long-needed tool for decision-makers, guideline developers and the public at large.

show abstract

A quality evaluation of guidelines on five different viruses causing public health emergencies of international concern

Cited by 24 publications

References 8 publications

Consistency of recommendations and methodological quality of guidelines for the diagnosis and treatment of COVID‐19

Consistency of recommendations and methodological quality of guidelines for the diagnosis and treatment of COVID‐19

The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and Explanation

Getting trustworthy guidelines into the hands of decision-makers and supporting their consideration of contextual factors for implementation globally: recommendation mapping of COVID-19 guidelines

Contact Info

Product

Resources

About